133 related articles for article (PubMed ID: 9299458)
21. Differential responses of human monocytes and macrophages to IL-4 and IL-13.
Hart PH; Bonder CS; Balogh J; Dickensheets HL; Donnelly RP; Finlay-Jones JJ
J Leukoc Biol; 1999 Oct; 66(4):575-8. PubMed ID: 10534111
[TBL] [Abstract][Full Text] [Related]
22. Binding of interleukin-13 and interleukin-4 to the interleukin (IL)-4/IL-13 receptor of human synovial fibroblasts.
Lutz RA; Feng N; Moser R
J Recept Signal Transduct Res; 1999; 19(1-4):181-90. PubMed ID: 10071757
[TBL] [Abstract][Full Text] [Related]
23. STAT-1 is activated by IL-4 and IL-13 in multiple cell types.
Wang IM; Lin H; Goldman SJ; Kobayashi M
Mol Immunol; 2004 Jul; 41(9):873-84. PubMed ID: 15261459
[TBL] [Abstract][Full Text] [Related]
24. Opposing roles for IL-13 and IL-13 receptor alpha 2 in health and disease.
Mentink-Kane MM; Wynn TA
Immunol Rev; 2004 Dec; 202():191-202. PubMed ID: 15546394
[TBL] [Abstract][Full Text] [Related]
25. Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors.
Kawakami M; Kawakami K; Takahashi S; Abe M; Puri RK
Cancer; 2004 Sep; 101(5):1036-42. PubMed ID: 15329913
[TBL] [Abstract][Full Text] [Related]
26. Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activation.
Umeshita-Suyama R; Sugimoto R; Akaiwa M; Arima K; Yu B; Wada M; Kuwano M; Nakajima K; Hamasaki N; Izuhara K
Int Immunol; 2000 Nov; 12(11):1499-509. PubMed ID: 11058569
[TBL] [Abstract][Full Text] [Related]
27. Regulation of interleukin-2 and interleukin-4 receptor expression in human and ape lymphoid cell lines.
Guizani L; Lang P; Stancou R; Bertoglio J
Lymphokine Cytokine Res; 1993 Feb; 12(1):25-32. PubMed ID: 8457629
[TBL] [Abstract][Full Text] [Related]
28. Characterization of interleukin-13 receptor in carcinoma cell lines and human blood cells and comparison with the interleukin-4 receptor.
Feng N; Schnyder B; Vonderschmitt DJ; Ryffel B; Lutz RA
J Recept Signal Transduct Res; 1995; 15(7-8):931-49. PubMed ID: 8673724
[TBL] [Abstract][Full Text] [Related]
29. Characterization of interleukin-4 receptors expressed on human renal cell carcinoma cells.
Obiri NI; Puri RK
Oncol Res; 1994; 6(9):419-27. PubMed ID: 7703528
[TBL] [Abstract][Full Text] [Related]
30. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
[TBL] [Abstract][Full Text] [Related]
31. Human melanoma cells release soluble and functional receptors.
Badr G; Sayed D
Egypt J Immunol; 2006; 13(2):23-31. PubMed ID: 18689268
[TBL] [Abstract][Full Text] [Related]
32. Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: comparison between IL-4- and IL-13-induced signal transduction.
Murata T; Obiri NI; Puri RK
Int J Cancer; 1997 Jan; 70(2):230-40. PubMed ID: 9009165
[TBL] [Abstract][Full Text] [Related]
33. Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases.
Joshi BH; Hogaboam C; Dover P; Husain SR; Puri RK
Vitam Horm; 2006; 74():479-504. PubMed ID: 17027527
[TBL] [Abstract][Full Text] [Related]
34. Diminished responses to IL-13 by human monocytes differentiated in vitro: role of the IL-13Ralpha1 chain and STAT6.
Hart PH; Bonder CS; Balogh J; Dickensheets HL; Vazquez N; Davies KV; Finlay-Jones JJ; Donnelly RP
Eur J Immunol; 1999 Jul; 29(7):2087-97. PubMed ID: 10427971
[TBL] [Abstract][Full Text] [Related]
35. Combined effects of radiation and interleukin-13 receptor-targeted cytotoxin on glioblastoma cell lines.
Kawakami K; Kawakami M; Liu Q; Puri RK
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):230-7. PubMed ID: 16111594
[TBL] [Abstract][Full Text] [Related]
36. Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin.
Kioi M; Kawakami K; Puri RK
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6231-8. PubMed ID: 15448012
[TBL] [Abstract][Full Text] [Related]
37. Expression of a functional IL-13Ralpha1 by rat B cells.
Pierrot C; Beniguel L; Bègue A; Khalife J
Biochem Biophys Res Commun; 2001 Oct; 287(4):969-76. PubMed ID: 11573960
[TBL] [Abstract][Full Text] [Related]
38. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
Niiya M; Niiya K; Kiguchi T; Shibakura M; Asaumi N; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Ueoka H; Tanimoto M
Cancer Chemother Pharmacol; 2003 Nov; 52(5):391-8. PubMed ID: 12908082
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-11 receptor expression in primary ovarian carcinomas.
Campbell CL; Guardiani R; Ollari C; Nelson BE; Quesenberry PJ; Savarese TM
Gynecol Oncol; 2001 Feb; 80(2):121-7. PubMed ID: 11161848
[TBL] [Abstract][Full Text] [Related]
40. A bispecific immunotoxin (DTAT13) targeting human IL-13 receptor (IL-13R) and urokinase-type plasminogen activator receptor (uPAR) in a mouse xenograft model.
Todhunter DA; Hall WA; Rustamzadeh E; Shu Y; Doumbia SO; Vallera DA
Protein Eng Des Sel; 2004 Feb; 17(2):157-64. PubMed ID: 15047912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
